Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

Abstract Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular dysplasia resulting in visceral arteriovenous malformations and smaller mucocutaneous telangiectasia. Most patients experience recurrent nosebleeds and become anemic without iron supplementation. However, thousands ma...

Full description

Bibliographic Details
Main Authors: C. L. Shovlin, C. M. Millar, F. Droege, A. Kjeldsen, G. Manfredi, P. Suppressa, S. Ugolini, N. Coote, A. D. Fialla, U. Geisthoff, G. M. Lenato, H. J. Mager, F. Pagella, M. C. Post, C. Sabbà, U. Sure, P. M. Torring, S. Dupuis-Girod, E. Buscarini, VASCERN-HHT
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Apixaban
Atrial fibrillation
Dabigatran
Epistaxis
Heparin
Pulmonary emboli
Online Access:http://link.springer.com/article/10.1186/s13023-019-1179-1

Internet

http://link.springer.com/article/10.1186/s13023-019-1179-1

Similar Items